SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001123292-21-001062
Filing Date
2021-06-30
Accepted
2021-06-30 16:17:41
Documents
2
Group Members
BLUE HORIZON ENTERPRISE LTD.EZBON INTERNATIONAL LTDMONTRAGO TRUSTEES LTD

Document Format Files

Seq Description Document Type Size
1 akero13g.htm SC 13G 261701
2 image00004.jpg GRAPHIC 41595
  Complete submission text file 0001123292-21-001062.txt   320603
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91047 | Film No.: 211062131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030
Business Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030 3-572-511-0165
Skorpios Trust (Filed by) CIK: 0001869333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G4 | Fiscal Year End: 1231
Type: SC 13G